SUBLOCADE Long-term Outcomes

ID#: NCT05860959

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: August 31, 2023

End Date: August 01, 2027

Contact Information:
Global Director Clinical Development
(804) 594-4488
Summary: This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
Eligibility:

Inclusion Criteria: Participants must meet all of the following criteria:

- Is an adult ≥ 18 years of age who has signed the informed consent form

- Plans to receive additional SUBLOCADE injections and

- Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit

- OR

- Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit

- Is not currently participating in any clinical trial requiring medical intervention

- Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
Find a Clinical Trial Find Cancer Clinical Trials